These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1245 related items for PubMed ID: 17439296

  • 1. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F.
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [Abstract] [Full Text] [Related]

  • 2. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G.
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [Abstract] [Full Text] [Related]

  • 3. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
    Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP.
    J Neurol Sci; 2010 Apr 15; 291(1-2):52-6. PubMed ID: 20117794
    [Abstract] [Full Text] [Related]

  • 4. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.
    Brain; 2007 May 15; 130(Pt 5):1194-205. PubMed ID: 17282996
    [Abstract] [Full Text] [Related]

  • 5. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.
    Brain; 2007 May 15; 130(Pt 5):1235-43. PubMed ID: 17449477
    [Abstract] [Full Text] [Related]

  • 6. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
    Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W.
    Brain; 2008 Nov 15; 131(Pt 11):3072-80. PubMed ID: 18945724
    [Abstract] [Full Text] [Related]

  • 7. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T, Fujihara K, Itoyama Y.
    Brain Nerve; 2008 May 15; 60(5):527-37. PubMed ID: 18516975
    [Abstract] [Full Text] [Related]

  • 8. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S.
    J Neuroimmunol; 2008 May 30; 196(1-2):181-7. PubMed ID: 18462810
    [Abstract] [Full Text] [Related]

  • 9. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.
    Rinsho Byori; 2009 Mar 30; 57(3):262-70. PubMed ID: 19363997
    [Abstract] [Full Text] [Related]

  • 10. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
    Wu L, Yang Y, Huang DH, Wu WP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb 30; 31(2):350-2. PubMed ID: 21354891
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.
    Brain; 2007 May 30; 130(Pt 5):1206-23. PubMed ID: 17439988
    [Abstract] [Full Text] [Related]

  • 12. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.
    Arch Neurol; 2009 Sep 30; 66(9):1164-7. PubMed ID: 19752309
    [Abstract] [Full Text] [Related]

  • 13. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
    Ketelslegers IA, Modderman PW, Vennegoor A, Killestein J, Hamann D, Hintzen RQ.
    Mult Scler; 2011 Dec 30; 17(12):1527-30. PubMed ID: 21828202
    [Abstract] [Full Text] [Related]

  • 14. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.
    Brain; 2007 May 30; 130(Pt 5):1224-34. PubMed ID: 17405762
    [Abstract] [Full Text] [Related]

  • 15. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
    Kim W, Lee JE, Li XF, Kim SH, Han BG, Lee BI, Kim JK, Choi K, Kim HJ.
    Mult Scler; 2012 May 30; 18(5):578-86. PubMed ID: 21965418
    [Abstract] [Full Text] [Related]

  • 16. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.
    Semin Ophthalmol; 2008 May 30; 23(3):191-200. PubMed ID: 18432545
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B.
    Nat Clin Pract Neurol; 2008 Apr 30; 4(4):202-14. PubMed ID: 18334978
    [Abstract] [Full Text] [Related]

  • 18. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
    Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M, Lia A, Trojano M, Frigeri A, Svelto M.
    Glia; 2009 Oct 30; 57(13):1363-73. PubMed ID: 19229993
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.
    J Neurol Sci; 2011 Jul 15; 306(1-2):82-90. PubMed ID: 21550068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.